Goldman Sachs
VSEE

Goldman Sachs’s VSee Health VSEE Stock Holding History

Goldman Sachs’s Portfolio VSEE Stock Details VSEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-70,628
Closed -$708K – 6577
2022
Q2 		$708K Hold
70,628
– – ﹤0.01% 4853
2022
Q1 		$706K Buy
70,628
+30,578
+76% +$304K ﹤0.01% 5098
2021
Q4 		$396K Buy
+40,050
New +$396K ﹤0.01% 5520

Other funds holding VSEE

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Goldman Sachs's VSEE Position: Q3 2022 in Review

Goldman Sachs sold out of VSee Health (VSEE) in Q3 2022, closing a stake of 70,628 shares — an estimated $708K sold.

Goldman Sachs first reported a position in VSEE in Q4 2021 and held it in 3 quarters. The position peaked at $708K in Q2 2022. 38 funds tracked by Wall St. Rank hold VSEE as of Q3 2022.

  • Goldman Sachs reported no remaining VSee Health position as of Q3 2022 after selling out during the quarter.
  • Goldman Sachs sold 70,628 VSee Health shares in Q3 2022, an estimated $708K.
  • Goldman Sachs first reported a position in VSee Health in Q4 2021 and held it in 3 quarters.
  • Goldman Sachs's VSee Health position peaked at $708K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held VSee Health as of Q3 2022.

Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.